Speciality Medicines Limited IPO 2026: Date, Price Band ₹117 to ₹124, GMP & Allotment

Speciality Medicines Limited IPO 2026
SM
Speciality Medicines Limited IPO
Speciality Pharma · Finished Formulations · Global Marketing · CDMO
📋 SME IPO Fresh Issue BSE SME
₹124
Upper Price
₹29.14 Cr
Issue Size
Mar 30, 2026
Listing Date
₹108.94 Cr
Market Cap (Pre)
📅 IPO Timetable
Tentative dates
🟢
IPO Opens
Friday, 20 March 2026
Bidding starts — apply before close
🔒
IPO Closes
Tuesday, 24 March 2026
Last day to bid — closes at 5:00 PM IST
📊
Basis of Allotment
Wednesday, 25 March 2026
Allotment finalised by registrar
🔄
Refund & Share Credit
Friday, 27 March 2026
Unallotted funds returned; shares credited to demat
🏷️
Monday, 30 March 2026
Trading begins on BSE SME at 10:00 AM IST
📋 IPO Details
Key issue information
IPO Open Date20 March 2026 (Fri)
IPO Close Date24 March 2026 (Tue)
Listing Date30 March 2026 (Mon)
Face Value₹10 per share
Price Band₹117 to ₹124
Issue Price (Upper)₹124 per share
Issue TypeBook Build — Fresh Issue
Lot Size1,000 shares
Total Issue Size23,50,000 shares (₹29.14 Cr)
Net Offered to Public22,00,000 shares (₹27.28 Cr)
Market Maker Reservation1,50,000 shares (₹1.86 Cr)
Pre-Issue Shares64,35,796
Post-Issue Shares87,85,796
Market Cap (Pre-IPO)₹108.94 Cr
Lead ManagerUnistone Capital Pvt.Ltd.
RegistrarSkyline Financial Services Pvt.Ltd.
💰 Lot Size & Minimum Investment
At upper price ₹124
Investor TypeLotsSharesAmount
Retail — Minimum & Maximum22,000₹2,48,000
S-HNI (sNII) — Min33,000₹3,72,000
S-HNI (sNII) — Max88,000₹9,92,000
B-HNI (bNII) — Min99,000₹11,16,000
⚠️ SME IPO Note: Investors can bid for a minimum of 2,000 shares and in multiples of 1,000 shares thereafter. Retail maximum application is 2 lots only.
👥 Investor Reservation
Allocated portion of Net Issue
Not more than 2%
QIB Portion
Not less than 49%
Retail Portion
Not less than 49%
NII Portion
📈 Company Financials
Restated Standalone · ₹ Crore
Metric31 Oct 202531 Mar 202531 Mar 2024
Total Assets45.5739.9822.68
Total Income36.9358.5427.66
PAT6.068.612.93
EBITDA6.519.095.26
Net Worth36.4730.4215.06
Total Borrowings4.815.052.86
Revenue Performance
FY 2023–24₹27.66 Cr
FY 2024–25₹58.54 Cr
7M FY26 (Apr–Oct 2025)₹36.93 Cr
📊 Key Performance Indicators
37.85%
ROE
FY 2024–25
33.39%
ROCE
FY 2024–25
14.77%
PAT Margin
FY 2024–25
15.60%
EBITDA Margin
FY 2024–25
18.11%
ROE (7M)
Oct 31, 2025
0.13x
Debt/Equity
Oct 31, 2025
💹 Valuation & EPS
Pre-IPO EPS
₹13.38
Based on Mar 31, 2025 Earnings
P/E: 9.27x
Post-IPO EPS
₹11.82
Annualised Oct 31, 2025 Earnings
P/E: 10.49x
ℹ️ Pre-IPO EPS is calculated based on shareholding as of RHP date and FY25 earnings. Post-issue EPS is based on annualized 7M FY26 earnings. Market cap at upper band is ₹108.94 Cr.
🎯 Objects of the Issue
Net proceeds utilisation
Setting up of Research and Development (R&D) Centre in Valsad, Gujarat
₹12.68 Cr
Funding for Working Capital Requirements
₹8.00 Cr
Product Registration and Development in International Markets
₹2.99 Cr
Marketing and Promotional Activities
₹1.66 Cr
Total Strategic Objects ₹25.33 Cr
🏢 About Speciality Medicines Limited
Est. 2021 · Ahmedabad · Pharma Formulations

Incorporated in 2021, Speciality Medicines Limited is an emerging player in the marketing and distribution of finished pharmaceutical formulations. It specializes in high-cost oral and injectable medications for chronic conditions. The company operates across 20+ Indian states and 35+ countries worldwide, with a strong focus on emerging markets like Jordan, Ethiopia, and Namibia.

The company follows a dual business model: Contract Manufacturing for export and direct marketing of sourced products. As of February 2026, it has 7 products registered overseas with 54 more in the registration pipeline. Its diverse dosage forms include everything from tablets and capsules to complex infusions and nasal sprays.

Global Operations
🌎
Global Footprint
Network spanning over 35 countries and 20+ states in India
📋
Registration Pipeline
7 registered products; 54 pending across 5 international markets
⚖️
Business Model
Mix of Contract Manufacturing and direct Specialty Pharma distribution
💊
Formulations
Wide range: Tablets, Injections, Nasal Sprays, Inhalers, and Ointments
Competitive Strengths
🌐Diversified global presence with exposure to high-growth emerging markets
📦Extensive product portfolio catering to complex chronic therapeutic areas
🤝Long-standing client relationships in regulated and semi-regulated markets
Strong focus on quality assurance and international regulatory compliance
Company Promoters
PG
Mr. Parth B Goyani
Promoter, Speciality Medicines Limited
GS
Mr. Goyani Sumit Babubhai
Promoter, Speciality Medicines Limited
📅 Key Dates
IPO Opens20 Mar 2026
IPO Closes24 Mar 2026
Allotment25 Mar 2026
Refund & Share Credit27 Mar 2026
Listing Day30 Mar 2026
💡 Quick Summary
Price Band₹117 – ₹124
Issue Price₹124 / share
Lot Size1,000 shares
Min. Investment (Retail)₹2,48,000 (2 lots)
Issue Size₹29.14 Cr
ListingBSE SME
🏦 Registrar & Lead Manager
Registrar
Skyline Financial Services Pvt.Ltd.
📞 022-28511022
ipo@skylinerta.com
Lead Manager
Unistone Capital Pvt.Ltd.
Market Maker
Aikyam Capital Private Limited
📍 Registered Address
Speciality Medicines Limited
913, One World West, FP 119,
Village- Vejalpur, Ahmadabad City,
Ahmedabad, Gujarat — 380051
📞 +91 22 4604 5344
investors.grievances@specialitymedicine.com
🛡️ Regulatory Note: SME IPO investments are subject to SEBI regulations. Always read the Prospectus/RHP before applying. Consult a SEBI-registered advisor before investing.
⚠️ Disclaimer: This page presents publicly available information from the Speciality Medicines IPO RHP for informational purposes only. It does not constitute investment advice. IPO investments are subject to market risk. Please read all offer documents and consult a SEBI-registered advisor before investing.
📊
Track Speciality Medicines Limited IPO 2026: Date, Price Band ₹117 to ₹124, GMP & Allotment GMP
Check real-time grey market premium, daily GMP history & estimated listing price.
Check GMP →

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top